Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study
Top Cited Papers
- 1 April 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 355 (9211) , 1205-1210
- https://doi.org/10.1016/s0140-6736(00)02085-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Acute Stroke With Atrial FibrillationStroke, 1996
- Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.Stroke, 1994
- Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project)BMJ, 1992
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke.Stroke, 1988
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988
- Multicenter trial of hemodilution in ischemic stroke--background and study protocol. Scandinavian Stroke Study Group.Stroke, 1985
- Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Cerebral Embolism Study Group.Stroke, 1984
- Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group.Stroke, 1983